The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by O'neill Julie since 2015.
The trader's CIK number is 1630299.
At the time of the last reporting, O'neill Julie was the EVP. Global Operations of Alexion Pharmaceuticals, Inc.. (stock ticker symbol ALXN).
Also see all insider trading activities at Alexion Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | ALXN | 0 | $0 | 8,531 | $999,970 | 0 | $0 |
| 2017 | ALXN | 0 | $0 | 20,555 | $2,844,191 | 0 | $0 |
| 2016 | ALXN | 0 | $0 | 4,822 | $678,036 | 0 | $0 |
| 2015 | ALXN | 0 | $0 | 13,107 | $1,431,124 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-02-27 | ALXN | Sale | 939 | 120.72 | 113,356 |
| 2018-02-28 | ALXN | Sale | 686 | 118.61 | 81,366 |
| 2018-02-08 | ALXN | Sale | 4,787 | 116.31 | 556,775 |
| 2018-02-05 | ALXN | Sale | 2,119 | 117.26 | 248,473 |
| 2017-09-05 | ALXN | Sale | 3,763 | 146.06 | 549,642 |
| 2017-08-31 | ALXN | Sale | 612 | 142.00 | 86,904 |
| 2017-08-28 | ALXN | Sale | 11,160 | 140.00 | 1,562,400 |
| 2017-03-02 | ALXN | Sale | 651 | 133.80 | 87,103 |
| 2017-02-27 | ALXN | Sale | 910 | 131.20 | 119,391 |
| 2017-02-28 | ALXN | Sale | 664 | 131.70 | 87,448 |
| 2017-02-06 | ALXN | Sale | 2,795 | 125.69 | 351,303 |
| 2016-09-02 | ALXN | Sale | 650 | 126.29 | 82,088 |
| 2016-03-02 | ALXN | Sale | 651 | 149.55 | 97,357 |
| 2016-02-29 | ALXN | Sale | 663 | 138.91 | 92,097 |
| 2016-02-05 | ALXN | Sale | 2,080 | 143.48 | 298,442 |
| 2016-02-08 | ALXN | Sale | 778 | 138.88 | 108,052 |
| 2015-09-02 | ALXN | Sale | 647 | 171.76 | 111,128 |
| 2015-02-27 | ALXN | Sale | 5,100 | .00 | 0 |
| 2015-03-02 | ALXN | Sale | 6,565 | 180.34 | 1,183,932 |
| 2015-02-10 | ALXN | Sale | 795 | 171.15 | 136,064 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by O'neill Julie (EVP. Global Operations of Alexion Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.